• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾小球肾炎中的高血压

Hypertension in Chronic Glomerulonephritis.

作者信息

Ihm Chun-Gyoo

机构信息

Division of Nephrology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Korea.

出版信息

Electrolyte Blood Press. 2015 Dec;13(2):41-5. doi: 10.5049/EBP.2015.13.2.41. Epub 2015 Dec 30.

DOI:10.5049/EBP.2015.13.2.41
PMID:26848302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4737660/
Abstract

Chronic glomerulonephritis (GN), which includes focal segmental glomerulosclerosis and proliferative forms of GN such as IgA nephropathy, increases the risk of hypertension. Hypertension in chronic GN is primarily volume dependent, and this increase in blood volume is not related to the deterioration of renal function. Patients with chronic GN become salt sensitive as renal damage including arteriolosclerosis progresses and the consequent renal ischemia causes the stimulation of the intrarenal renin-angiotensin-aldosterone system(RAAS). Overactivity of the sympathetic nervous system also contributes to hypertension in chronic GN. According to the KDIGO guideline, the available evidence indicates that the target BP should be ≤140mmHg systolic and ≤90mmHg diastolic in chronic kidney disease patients without albuminuria. In most patients with an albumin excretion rate of ≥30mg/24 h (i.e., those with both micro-and macroalbuminuria), a lower target of ≤130mmHg systolic and ≤80mmHg diastolic is suggested. The use of agents that block the RAAS system is recommended or suggested in all patients with an albumin excretion rate of ≥30mg/ 24 h. The combination of a RAAS blockade with a calcium channel blocker and a diuretic may be effective in attaining the target BP, and in reducing the amount of urinary protein excretion in patients with chronic GN.

摘要

慢性肾小球肾炎(GN),包括局灶节段性肾小球硬化症以及增殖性GN形式,如IgA肾病,会增加患高血压的风险。慢性GN中的高血压主要取决于血容量,而血容量的增加与肾功能恶化无关。随着包括小动脉硬化在内的肾损伤进展,以及随之而来的肾缺血导致肾内肾素 - 血管紧张素 - 醛固酮系统(RAAS)受到刺激,慢性GN患者会变得对盐敏感。交感神经系统的过度活跃也会导致慢性GN患者出现高血压。根据KDIGO指南,现有证据表明,对于无蛋白尿慢性肾病患者,目标血压应为收缩压≤140mmHg和舒张压≤90mmHg。对于大多数白蛋白排泄率≥30mg/24小时的患者(即微量白蛋白尿和大量白蛋白尿患者),建议将目标血压降至更低,即收缩压≤130mmHg和舒张压≤80mmHg。对于所有白蛋白排泄率≥30mg/24小时的患者,建议使用阻断RAAS系统的药物。RAAS阻断剂与钙通道阻滞剂和利尿剂联合使用,可能有助于慢性GN患者达到目标血压,并减少尿蛋白排泄量。

相似文献

1
Hypertension in Chronic Glomerulonephritis.慢性肾小球肾炎中的高血压
Electrolyte Blood Press. 2015 Dec;13(2):41-5. doi: 10.5049/EBP.2015.13.2.41. Epub 2015 Dec 30.
2
Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.肾素-血管紧张素-醛固酮系统阻断剂治疗的肾移植受者限制饮食钠摄入的效果:一项随机临床试验。
Am J Kidney Dis. 2016 Jun;67(6):936-44. doi: 10.1053/j.ajkd.2015.11.026. Epub 2016 Jan 21.
3
Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.治疗中难治性高血压(ResHypOT):与肾素-血管紧张素-醛固酮系统双重阻断加比索洛尔相比,序贯肾单位阻断治疗难治性动脉高血压——一项随机对照试验的研究方案
Trials. 2018 Feb 12;19(1):101. doi: 10.1186/s13063-017-2343-3.
4
Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?KDIGO 指南摘要。我们对慢性肾脏病患者血压管理的了解到底有多少?
Kidney Int. 2013 Mar;83(3):377-83. doi: 10.1038/ki.2012.425. Epub 2013 Jan 16.
5
Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.尿肾素而非血管紧张素原或醛固酮反映了肾脏肾素-血管紧张素-醛固酮系统的活性和肾素-血管紧张素-醛固酮系统阻断剂在肾脏中的疗效。
J Hypertens. 2011 Nov;29(11):2147-55. doi: 10.1097/HJH.0b013e32834bbcbf.
6
Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients.夜间高血压导致的肾内肾素-血管紧张素系统的夜间激活与正常血压 IgA 肾病患者的肾动脉硬化有关。
Hypertens Res. 2018 May;41(5):334-341. doi: 10.1038/s41440-018-0026-4. Epub 2018 Mar 5.
7
Urinary renin-angiotensin markers in polycystic kidney disease.多囊肾病中的尿肾素-血管紧张素标志物
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F874-F881. doi: 10.1152/ajprenal.00209.2017. Epub 2017 Jul 26.
8
DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.慢性肾小球肾炎中的DNA片段化:一项免疫组织学分析
Nephron Clin Pract. 2007;105(1):c18-28. doi: 10.1159/000096981. Epub 2006 Nov 15.
9
T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?接受免疫抑制药物治疗的原发性肾小球肾炎患者尿液中的辅助性T细胞(Th)细胞因子:它们能否预测预后?
Cytokine. 2015 Dec;76(2):260-269. doi: 10.1016/j.cyto.2015.08.002. Epub 2015 Aug 22.
10
[The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].[肾小管间质改变在慢性肾小球肾炎(GN)患者肾功能衰竭进展中的作用]
Przegl Lek. 1996;53(5):443-53.

引用本文的文献

1
The interplay between the cardiovascular system and pediatric congenital or acquired kidney diseases.心血管系统与小儿先天性或后天性肾脏疾病之间的相互作用。
Pediatr Nephrol. 2025 Mar 26. doi: 10.1007/s00467-025-06750-0.
2
DOME: Directional medical embedding vectors from Electronic Health Records.DOME:来自电子健康记录的定向医学嵌入向量。
J Biomed Inform. 2025 Feb;162:104768. doi: 10.1016/j.jbi.2024.104768. Epub 2025 Jan 2.
3
Angiotensin II-independent abnormal renal vascular reactivity during puromycin nephropathy.在嘌呤霉素肾病期间,血管紧张素 II 非依赖性异常肾脏血管反应性。
J Med Life. 2024 Mar;17(3):309-313. doi: 10.25122/jml-2023-0367.
4
Blood Pressure Control and its Determinants among Patients with Chronic Kidney Disease in a Nigerian Tertiary Hospital: A Cross-Sectional Study.尼日利亚一家三级医院慢性肾脏病患者的血压控制及其影响因素:一项横断面研究
Niger Med J. 2023 Feb 24;63(5):394-401. eCollection 2022 Sep-Oct.
5
Cardiovascular Risk in Patients With Glomerular Disease: A Narrative Review of the Epidemiology, Mechanisms, Management, and Patient Priorities.肾小球疾病患者的心血管风险:关于流行病学、机制、管理及患者优先事项的叙述性综述
Can J Kidney Health Dis. 2024 Feb 22;11:20543581241232472. doi: 10.1177/20543581241232472. eCollection 2024.
6
The issue of atherosclerosis in primary glomerulonephritis.原发性肾小球肾炎中的动脉粥样硬化问题。
J Bras Nefrol. 2024 Jan-Mar;46(1):3-4. doi: 10.1590/2175-8239-JBN-2023-E015en.
7
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases.肾小球疾病相关高血压的发病机制与治疗。
Curr Hypertens Rep. 2024 Mar;26(3):119-130. doi: 10.1007/s11906-023-01287-9. Epub 2023 Nov 20.
8
Chronic Glomerulonephritis and Malignant Hypertension With PRES (Posterior Reversible Encephalopathy Syndrome) Presenting As Status Epilepticus: A Case Report.以癫痫持续状态为表现的慢性肾小球肾炎和伴有后部可逆性脑病综合征(PRES)的恶性高血压:一例报告
Cureus. 2023 Aug 22;15(8):e43902. doi: 10.7759/cureus.43902. eCollection 2023 Aug.
9
Prognostic significance of circulating microparticles in IgA nephropathy.循环微颗粒在IgA肾病中的预后意义。
Int Urol Nephrol. 2024 Mar;56(3):1071-1081. doi: 10.1007/s11255-023-03743-6. Epub 2023 Aug 24.
10
Knowledgebase strategies to aid interpretation of clinical correlation research.知识库策略辅助临床关联研究解读。
J Am Med Inform Assoc. 2023 Jun 20;30(7):1257-1265. doi: 10.1093/jamia/ocad078.

本文引用的文献

1
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
2
Blood pressure in early autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病早期的血压情况
N Engl J Med. 2014 Dec 11;371(24):2255-66. doi: 10.1056/NEJMoa1402685. Epub 2014 Nov 15.
3
Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis.小动脉玻璃样变性和动脉高血压作为肾小球肾炎中间质血流减少和缺氧的可能替代标志物。
Nephrology (Carlton). 2015 Jan;20(1):11-7. doi: 10.1111/nep.12339.
4
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).2014 年成人高血压管理的循证指南:第八届联合国家委员会(JNC 8)任命的专家组报告。
JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427.
5
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.2013年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理实践指南:ESH/ESC动脉高血压管理特别工作组
J Hypertens. 2013 Oct;31(10):1925-38. doi: 10.1097/HJH.0b013e328364ca4c.
6
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.慢性肾脏病的评估与管理:肾脏病:改善全球预后 2012 临床实践指南概要。
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
7
Association of C1q deposition with renal outcomes in IgA nephropathy.C1q沉积与IgA肾病肾脏结局的关联。
Clin Nephrol. 2013 Aug;80(2):98-104. doi: 10.5414/CN107854.
8
Relationship between glomerulomegaly and clinicopathologic findings in IgA nephropathy.IgA肾病中肾小球肿大与临床病理表现的关系。
Clin Nephrol. 2012 Dec;78(6):470-7. doi: 10.5414/CN107614.
9
Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.导致免疫球蛋白 A 肾病高血压的基因多态性。
Clin Exp Nephrol. 2012 Apr;16(2):250-8. doi: 10.1007/s10157-011-0553-7. Epub 2011 Nov 11.
10
Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.尿血管紧张素原作为 IgA 肾病患者的预测标志物。
Clin Exp Nephrol. 2011 Oct;15(5):720-726. doi: 10.1007/s10157-011-0475-4. Epub 2011 Jun 22.